To date, there are highly effective lipid-lowering drugs, the combination of which makes it possible to achieve the target level of LDL-C in most patients with familial hypercholesterolemia (FH). However, the effectiveness of treatment of FH patients strongly depends on adherence to lipid-lowering therapy and to the healthy lifestyle, as well as the detection of the disease and the therapy prescription as early as possible, better in childhood. The aim of the study is to assess the impact of genetic testing and motivational counseling on the effectiveness of treatment and cascade screening in patients with FH.
There are several tasks of the study:
Condition | genetic test, Psychological Counseling, Broad Beta Disease, genetic analysis, Hypercholesterolemia, Familial, 3, Compliance, Hypercholesterolemia, Familial, Due to Ligand-Defective Apolipoprotein B, Familial Hypercholesterolemia, Hypercholesterolemia Familial Due to Genetic Defect of Apolipoprotein B, Cascade Screening, Hypercholesterolemia, Familial, 1, Therapeutic Adherence and Compliance, Noncompliance with medication regimen, motivational enhancement therapy, Familial Hypercholesterolemia - Heterozygous, Hypercholesterolemia, Familial, 4, Autosomal Recessive, Treatment Adherence and Compliance, Familial Hypercholesterolemia Due to Heterozygous LDL Receptor Mutation, genetic tests, Hypercholesterolemia, Familial, 4, Treatment Adherence, Patient Compliance, Therapeutic Adherence, FAMILIAL HYPERCHOLESTEROLEMIA, Hypercholesterolemia, Autosomal Dominant, 3, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Fredrickson Type III Hyperlipoproteinemia, Hypercholesterolemia, Familial, 2, Motivational Interviewing, Adherence, Genetic Testing |
---|---|
Treatment | genetic testing, Motivational Counseling, Visit 1, Visit 2, Lipid analysis, Consultation with a cardiologist-lipidologist (correction of therapy, lifestyle, diet), Visit 3 |
Clinical Study Identifier | NCT04656028 |
Sponsor | National Medical Research Center for Therapy and Preventive Medicine |
Last Modified on | 1 November 2021 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.